Haynes and Boone represented NRX Pharmaceuticals, Inc. in the offering, and Sichenzia Ross Ference Carmel represented EF Hutton. NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), (“NRx Pharmaceuticals” or...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here